206 related articles for article (PubMed ID: 19968016)
1. Safety overview of postmarketing and clinical experience of sodium oxybate (Xyrem): abuse, misuse, dependence, and diversion.
Wang YG; Swick TJ; Carter LP; Thorpy MJ; Benowitz NL
J Clin Sleep Med; 2009 Aug; 5(4):365-71. PubMed ID: 19968016
[TBL] [Abstract][Full Text] [Related]
2. Development of a lower-sodium oxybate formulation for the treatment of patients with narcolepsy and idiopathic hypersomnia.
Junnarkar G; Allphin C; Profant J; Steininger TL; Chen C; Zomorodi K; Skowronski R; Black J
Expert Opin Drug Discov; 2022 Feb; 17(2):109-119. PubMed ID: 34818123
[TBL] [Abstract][Full Text] [Related]
3. The Xyrem risk management program.
Fuller DE; Hornfeldt CS; Kelloway JS; Stahl PJ; Anderson TF
Drug Saf; 2004; 27(5):293-306. PubMed ID: 15061684
[TBL] [Abstract][Full Text] [Related]
4. Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuse.
Carter LP; Pardi D; Gorsline J; Griffiths RR
Drug Alcohol Depend; 2009 Sep; 104(1-2):1-10. PubMed ID: 19493637
[TBL] [Abstract][Full Text] [Related]
5. From club drug to orphan drug: sodium oxybate (Xyrem) for the treatment of cataplexy.
Fuller DE; Hornfeldt CS
Pharmacotherapy; 2003 Sep; 23(9):1205-9. PubMed ID: 14524654
[TBL] [Abstract][Full Text] [Related]
6. Calcium, Magnesium, Potassium and Sodium Oxybates (Xywav
Heo YA
CNS Drugs; 2022 May; 36(5):541-549. PubMed ID: 35357671
[TBL] [Abstract][Full Text] [Related]
7. The clinical development of gamma-hydroxybutyrate (GHB).
Wedin GP; Hornfeldt CS; Ylitalo LM
Curr Drug Saf; 2006 Jan; 1(1):99-106. PubMed ID: 18690919
[TBL] [Abstract][Full Text] [Related]
8. Treatment of paediatric narcolepsy with sodium oxybate: a double-blind, placebo-controlled, randomised-withdrawal multicentre study and open-label investigation.
Plazzi G; Ruoff C; Lecendreux M; Dauvilliers Y; Rosen CL; Black J; Parvataneni R; Guinta D; Wang YG; Mignot E
Lancet Child Adolesc Health; 2018 Jul; 2(7):483-494. PubMed ID: 30169321
[TBL] [Abstract][Full Text] [Related]
9. Psychosis in the context of sodium oxybate therapy.
Langford J; Gross WL
J Clin Sleep Med; 2011 Dec; 7(6):665-6. PubMed ID: 22171207
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy.
Xyrem International Study Group
J Clin Sleep Med; 2005 Oct; 1(4):391-7. PubMed ID: 17564408
[TBL] [Abstract][Full Text] [Related]
11. The Xyrem
Strunc MJ; Black J; Lillaney P; Profant J; Mills S; Bujanover S; Thorpy MJ
Drugs Real World Outcomes; 2021 Mar; 8(1):15-28. PubMed ID: 33439474
[TBL] [Abstract][Full Text] [Related]
12. Sodium oxybate: new drug. Fewer attacks of cataplexy in some patients.
Prescrire Int; 2007 Jun; 16(89):98-101. PubMed ID: 17582923
[TBL] [Abstract][Full Text] [Related]
13. Sodium oxybate improves excessive daytime sleepiness in narcolepsy.
Black J; Houghton WC
Sleep; 2006 Jul; 29(7):939-46. PubMed ID: 16895262
[TBL] [Abstract][Full Text] [Related]
14. Xyrem (sodium oxybate) postmarketing adverse event reporting system.
Wang YG
Sleep Med; 2010 Jun; 11(6):595; author reply 595-6. PubMed ID: 20362501
[No Abstract] [Full Text] [Related]
15. Sodium oxybate for cataplexy.
Lemon MD; Strain JD; Farver DK
Ann Pharmacother; 2006 Mar; 40(3):433-40; quiz 581-2. PubMed ID: 16507620
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of long-term use of sodium oxybate for narcolepsy with cataplexy in routine clinical practice.
Drakatos P; Lykouras D; D'Ancona G; Higgins S; Gildeh N; Macavei R; Rosenzweig I; Steier J; Williams AJ; Muza R; Kent BD; Leschziner G
Sleep Med; 2017 Jul; 35():80-84. PubMed ID: 28619187
[TBL] [Abstract][Full Text] [Related]
17. Narcolepsy: treatment issues.
Roth T
J Clin Psychiatry; 2007; 68 Suppl 13():16-9. PubMed ID: 18078361
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of sodium oxybate as a treatment option for narcolepsy.
Abad VC
Expert Opin Pharmacother; 2019 Jul; 20(10):1189-1199. PubMed ID: 31136215
[No Abstract] [Full Text] [Related]
19. Time to response with sodium oxybate for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy.
Bogan RK; Roth T; Schwartz J; Miloslavsky M
J Clin Sleep Med; 2015 Apr; 11(4):427-32. PubMed ID: 25580605
[TBL] [Abstract][Full Text] [Related]
20. Clinical applications of sodium oxybate (GHB): from narcolepsy to alcohol withdrawal syndrome.
Busardò FP; Kyriakou C; Napoletano S; Marinelli E; Zaami S
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4654-63. PubMed ID: 26698265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
